Trial-Results center  
Clinical trial results database Feedback    Home


Related trials

ZEST AMI (vs SES), 2009 - zotarolimus ES vs sirolimus ES

TRIANA, 2009 - primary ballon angioplasty vs tenecteplase

DEBATER (SES vs BMS), 2009 - sirolimus ES vs bare-metal stent

NORDISTEMI, 2009 - thrombolysis + angioplasty vs immediate thrombolysis

Juwana, 2009 - sirolimus ES vs paclitaxel ES

ZEST AMI (vs PES), 2009 - zotarolimus ES vs paclitaxel ES

PASEO, 2009 - drug ES vs bare-metal stent

CARESS, 2008 - thrombolysis + angioplasty vs immediate thrombolysis

HORIZONS-AMI Stent, 2008 - paclitaxel ES vs bare-metal stent

MISSION, 2008 - sirolimus ES vs bare-metal stent

DEDICATION, 2008 - drug ES vs bare-metal stent

Díaz de la Llera, 2007 - sirolimus ES vs bare-metal stent

SESAMI, 2007 - sirolimus ES vs bare-metal stent

TYPHOON, 2006 - sirolimus ES vs bare-metal stent

PROSIT, 2006 - sirolimus ES vs paclitaxel ES

HAAMU-STENT, 2006 - paclitaxel ES vs bare-metal stent

PASSION, 2006 - paclitaxel ES vs bare-metal stent

WEST, 2006 - systematic PCI (+stent) vs no systematic PCI

ZWOLLE 6, 2005 - primary stenting vs ballon angioplasty

CAPITAL AMI, 2005 - systematic PCI (+stent) vs no systematic PCI

senior PAMI, 2005 - primary PCI vs thrombolytic therapy

CAPITAL AMI, 2005 - thrombolysis + angioplasty vs immediate thrombolysis

Di Lorenzo et al., 2005 - sirolimus ES vs paclitaxel ES

GRACIA-1, 2004 - systematic PCI (+stent) vs no systematic PCI

MERLIN (Sutton), 2004 - immediate systematic ballon angioplastyte vs no immediate angioplasty



See also:

  • All acute myocardial infarction clinical trials
  • All clinical trials of PCI
  • All clinical trials of primary ballon angioplasty
  •  

    Garcia study, 1997

    Treatments

    Studied treatment primary PTCA
    Control treatment accelerated t-PA 90 min (15 mg IV bolus followed by an infusion of 0.75 mg/kg over 30min not to exceed 50mg, and then 0.5 mg/kg over the next 60min not to exceed 35mg for a total maximun of 100mg)
    Concomittant treatment aspirin (135-325mg/d) heparin in the angioplasty group: bolus of 10000UI followed by 1000IU/h for 48h, in the t-PA group: 1000UI/h for 38h
    Treatments description
    Delay from symptoms 5h 

    Patients

    Patients patients with anterior AMI
    Inclusion criteria anterior myocardial infraction, <5h from the onset of pain,
    Baseline characteristics
    anterior MI 100% 
    inferior MI 0% 
    Delay to treatment (PTCA vs thr) 15 min 
    Diabetes NA 
    Previous MI NA 
    Killip>=2 NA 
    Mean EF NA 
    % female NA 
    mean age NA 

    Method and design

    Randomized effectives 95 / 94 (studied vs. control)
    Design Parallel groups
    Blinding open
    Follow-up duration 30 d
    Lost to follow-up ND
    Number of centre single center
    Geographic area Spain
    Hypothesis Superiority
    Withdrawals (T1/T0) ND /


    Results

    No results available for this trial - no clinical endpoint reported



    Reference(s)

    Trials register # NA
    • García E, Elízaga J, Pérez-Castellano N, Serrano JA, Soriano J, Abeytua M, Botas J, Rubio R, López de Sá E, López-Sendón JL, Delcán JL. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction.. J Am Coll Cardiol 1999;33:605-11
      Pubmed | Hubmed | Fulltext

    (c) 2004-2010 TrialResults-center - All Rights Reserved

    Tweet this  |  notify a friend